Chansel D, Oudinet J P, Nivez M P, Ardaillou R
Biochem Pharmacol. 1982 Feb 1;31(3):367-75. doi: 10.1016/0006-2952(82)90184-8.
The aim of this study was to demonstrate histamine-H2 receptors in glomeruli isolated from rat renal cortex and to correlate binding to stimulation by histamine of glomerular cyclic AMP concentration. Binding studies were performed at 10-12 degrees C using [3H]cimetidine as a tracer. Specificity of binding relies on the following: inhibition of [3H]cimetidine binding by the unlabelled drug, other H2-antagonists and agonists in contrast with the very weak inhibitory effects of H1 agonists and antagonists; reversibility of steady-state binding after addition of unlabelled drug; half inhibition of the glomerular cyclic AMP response to histamine at concentrations of cimetidine close to the KD value derived from the binding studies (3 microM); calculated KD value in agreement with the therapeutical concentration of cimetidine and the physiological concentration of histamine. [3H]Cimetidine binding concentration of cimetidine and the physiological concentration of histamine. [3H]Cimetidine binding strikingly increased in the presence of copper chloride (20-300 microM) due to an increase both in number of sites and affinity. However this greater binding did not influence either the inhibitory effect of cimetidine on histamine-induced glomerular cyclic AMP concentration or the stimulatory effect of histamine itself. [3H]Cimetidine binding was temperature-dependent since it progressively diminished from 0 to 37 degrees. This was not due to [3H]cimetidine degradation as shown by thin layer chromatography but rather to a change in drug-receptor interaction at higher temperatures. Glumerular concentration of cyclic AMP increased progressively in the presence of histamine (0.1-1000 microM). This stimulatory effect was markedly inhibited by H2 antagonists. These data demonstrate the presence in rat glomeruli of H2 receptors linked to adenylate cyclase.
本研究的目的是在从大鼠肾皮质分离出的肾小球中证实组胺 - H2受体,并将其结合与组胺对肾小球环磷酸腺苷(cAMP)浓度的刺激作用相关联。结合研究在10 - 12℃下使用[3H]西咪替丁作为示踪剂进行。结合的特异性基于以下几点:未标记药物、其他H2拮抗剂和激动剂对[3H]西咪替丁结合的抑制作用,与H1激动剂和拮抗剂非常微弱的抑制作用形成对比;加入未标记药物后稳态结合的可逆性;在西咪替丁浓度接近结合研究得出的KD值(3 microM)时,对组胺诱导的肾小球cAMP反应的半数抑制;计算得出的KD值与西咪替丁的治疗浓度和组胺的生理浓度一致。[3H]西咪替丁的结合在氯化铜(20 - 300 microM)存在下显著增加,这是由于位点数量和亲和力均增加。然而,这种更强的结合既不影响西咪替丁对组胺诱导的肾小球cAMP浓度的抑制作用,也不影响组胺本身的刺激作用。[3H]西咪替丁的结合是温度依赖性的,因为它从0℃到37℃逐渐减少。这并非由于[3H]西咪替丁降解,薄层色谱法已证明这一点,而是由于在较高温度下药物 - 受体相互作用发生了变化。在组胺(0.1 - 1000 microM)存在下,肾小球cAMP浓度逐渐增加。这种刺激作用被H2拮抗剂显著抑制。这些数据证明大鼠肾小球中存在与腺苷酸环化酶相关的H2受体。